Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for MYGN

Stock NameMyriad Genetics Inc
TickerMYGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS62855J1043
LEI52990044IHUOUMETT163

Show aggregate MYGN holdings

News associated with MYGN

Myriad Genetics, Inc. (NASDAQ:MYGN) Receives $14.38 Consensus PT from Analysts
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been assigned a consensus rating of “Hold” from the sixteen brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the […] - 2025-08-07 03:12:46
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 86,973 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 43.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 285,229 shares of the company’s stock after purchasing an additional 86,973 shares […] - 2025-06-05 06:14:55
Squarepoint Ops LLC Acquires 29,524 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Squarepoint Ops LLC boosted its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 27.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 138,869 shares of the company’s stock after acquiring an additional 29,524 shares during the period. Squarepoint […] - 2025-05-30 05:34:51
ProShare Advisors LLC Has $370,000 Stake in Myriad Genetics, Inc. (NASDAQ:MYGN)
ProShare Advisors LLC grew its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 12.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,982 shares of the company’s stock after purchasing an additional 2,933 shares during the period. ProShare Advisors LLC’s holdings […] - 2025-05-29 05:04:50
BNP Paribas Financial Markets Purchases 23,408 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
BNP Paribas Financial Markets boosted its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 51.1% in the fourth quarter, HoldingsChannel reports. The firm owned 69,183 shares of the company’s stock after buying an additional 23,408 shares during the quarter. BNP Paribas Financial Markets’ holdings in Myriad Genetics were worth $948,000 as of its […] - 2025-05-22 04:28:50
Myriad Genetics, Inc. (NASDAQ:MYGN) Stake Raised by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 4.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 197,001 shares of the company’s stock after purchasing an additional 8,073 […] - 2025-05-21 05:40:50
Myriad Genetics, Inc. (NASDAQ:MYGN) Shares Sold by Comerica Bank
Comerica Bank trimmed its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 7.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 32,747 shares of the company’s stock after selling 2,525 shares during the period. Comerica Bank’s holdings in Myriad […] - 2025-05-16 05:20:57
Tudor Investment Corp ET AL Boosts Stake in Myriad Genetics, Inc. (NASDAQ:MYGN)
Tudor Investment Corp ET AL boosted its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 212.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 49,935 shares of the company’s stock after acquiring an additional 33,937 shares […] - 2025-05-08 06:12:54
Hsbc Holdings PLC Buys 9,997 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Hsbc Holdings PLC grew its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 49.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,214 shares of the company’s stock after purchasing an additional 9,997 shares during the quarter. Hsbc Holdings […] - 2025-05-08 05:22:47
First Trust Advisors LP Sells 46,831 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
First Trust Advisors LP trimmed its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 25.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 139,545 shares of the company’s stock after selling 46,831 shares during the quarter. First Trust Advisors LP […] - 2025-05-06 05:41:06
Dimensional Fund Advisors LP Has $31.15 Million Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)
Dimensional Fund Advisors LP decreased its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 6.2% in the fourth quarter, HoldingsChannel reports. The firm owned 2,272,355 shares of the company’s stock after selling 151,122 shares during the period. Dimensional Fund Advisors LP’s holdings in Myriad Genetics were worth $31,154,000 at the end of the […] - 2025-05-06 04:42:53
How The Pieces Add Up: IJR Headed For $129
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:51:52
Analysts Set Myriad Genetics, Inc. (NASDAQ:MYGN) Price Target at $20.61
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have earned an average recommendation of “Hold” from the sixteen analysts that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. […] - 2025-04-29 02:50:53
Legal & General Group Plc Has $3.38 Million Stock Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)
Legal & General Group Plc decreased its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 246,146 shares of the company’s stock after selling 5,363 shares during […] - 2025-04-23 05:58:48
Arrowstreet Capital Limited Partnership Sells 24,519 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Arrowstreet Capital Limited Partnership cut its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 13.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 153,062 shares of the company’s stock after selling 24,519 shares during the period. Arrowstreet […] - 2025-04-11 06:07:13
KLP Kapitalforvaltning AS Purchases New Holdings in Myriad Genetics, Inc. (NASDAQ:MYGN)
KLP Kapitalforvaltning AS acquired a new position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 18,000 shares of the company’s stock, valued at approximately $247,000. Several other institutional investors and hedge funds have also recently added […] - 2025-04-08 04:32:51
Corebridge Financial Inc. Sells 3,716 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Corebridge Financial Inc. decreased its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 7.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 47,667 shares of the company’s stock after selling 3,716 shares during the quarter. Corebridge Financial Inc.’s holdings in Myriad Genetics were worth $654,000 at the end of the most recent […] - 2025-04-07 04:32:49
Prudential Financial Inc. Sells 126,550 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Prudential Financial Inc. lessened its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 37.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 209,131 shares of the company’s stock after selling 126,550 shares during the period. Prudential […] - 2025-04-03 05:18:51
Myriad Genetics (NASDAQ:MYGN) Price Target Cut to $20.00 by Analysts at Scotiabank
Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its target price lowered by Scotiabank from $24.00 to $20.00 in a note issued to investors on Tuesday,Benzinga reports. The firm currently has a “sector outperform” rating on the stock. Scotiabank’s price objective indicates a potential upside of 127.27% from the company’s current price. Several other research […] - 2025-04-03 04:24:52
Myriad Genetics (NASDAQ:MYGN) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a hold rating to a buy rating in a report released on Tuesday morning. Several other research analysts have also commented on MYGN. Stephens reissued an “equal weight” rating and issued a $20.00 price objective on shares of Myriad Genetics in a research report […] - 2025-03-26 04:38:45
Natixis Advisors LLC Sells 110,685 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Natixis Advisors LLC reduced its position in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 34.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 209,328 shares of the company’s stock after selling 110,685 shares during the quarter. Natixis Advisors LLC […] - 2025-03-24 05:54:59
Victory Capital Management Inc. Has $841,000 Stock Position in Myriad Genetics, Inc. (NASDAQ:MYGN)
Victory Capital Management Inc. lifted its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 6.4% during the 4th quarter, HoldingsChannel reports. The fund owned 61,341 shares of the company’s stock after buying an additional 3,711 shares during the period. Victory Capital Management Inc.’s holdings in Myriad Genetics were worth $841,000 as of its […] - 2025-03-21 07:10:48
AlphaQuest LLC Sells 5,360 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
AlphaQuest LLC lowered its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 67.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 2,641 shares of the company’s stock after selling 5,360 shares during the quarter. AlphaQuest LLC’s holdings in Myriad Genetics were worth $36,000 at the end of the most […] - 2025-03-21 06:08:54
Myriad Genetics (NASDAQ:MYGN) Downgraded by StockNews.com to “Hold”
StockNews.com cut shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a buy rating to a hold rating in a research note released on Thursday. A number of other equities research analysts also recently issued reports on the company. Morgan Stanley lowered their price objective on Myriad Genetics from $32.00 to $21.00 and set an […] - 2025-03-14 06:04:51
Nasdaq Climbs as Retaliatory Tariffs Spark Mixed Session on Wall Street
The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.43%. March E-mini S&P futures (ESH25 ) are up +0.79%, and March E-mini Nasdaq futures... - 2025-03-12 18:27:33
Myriad Genetics (NASDAQ:MYGN) Given New $11.50 Price Target at Piper Sandler
Myriad Genetics (NASDAQ:MYGN – Free Report) had its price objective cut by Piper Sandler from $14.00 to $11.50 in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have a neutral rating on the stock. Several other equities research analysts have also commented on MYGN. Leerink Partners lowered Myriad Genetics from an […] - 2025-03-05 06:45:04
Handelsbanken Fonder AB Acquires 3,500 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Handelsbanken Fonder AB boosted its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 12.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 30,788 shares of the company’s stock after acquiring an additional 3,500 shares during the quarter. Handelsbanken Fonder AB’s holdings […] - 2025-03-03 06:59:05
Raymond James Reiterates Outperform Rating for Myriad Genetics (NASDAQ:MYGN)
Raymond James reaffirmed their outperform rating on shares of Myriad Genetics (NASDAQ:MYGN – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $19.00 price objective on the stock, down from their previous price objective of $27.00. Other research analysts have also recently issued reports about the company. Bank of […] - 2025-02-26 06:56:56
Myriad Genetics (NASDAQ:MYGN) Hits New 1-Year Low Following Weak Earnings
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) hit a new 52-week low during trading on Tuesday following a dissappointing earnings announcement. The stock traded as low as $9.76 and last traded at $11.63, with a volume of 405660 shares changing hands. The stock had previously closed at $13.78. The company reported ($0.09) EPS for […] - 2025-02-26 04:20:57
New York State Teachers Retirement System Reduces Stake in Myriad Genetics, Inc. (NASDAQ:MYGN)
New York State Teachers Retirement System trimmed its stake in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 4.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 70,598 shares of the company’s stock after selling 3,302 shares during the […] - 2025-02-24 06:26:57

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc MYGN holdings

DateNumber of MYGN Shares HeldBase Market Value of MYGN SharesLocal Market Value of MYGN SharesChange in MYGN Shares HeldChange in MYGN Base ValueCurrent Price per MYGN Share HeldPrevious Price per MYGN Share Held
2025-11-13 (Thursday)90,027USD 571,671USD 571,671
2025-11-12 (Wednesday)90,027MYGN holding decreased by -296USD 588,777MYGN holding decreased by -14581USD 588,777-296USD -14,581 USD 6.54 USD 6.68
2025-11-11 (Tuesday)90,323USD 603,358MYGN holding increased by 18065USD 603,3580USD 18,065 USD 6.68 USD 6.48
2025-11-10 (Monday)90,323USD 585,293MYGN holding increased by 16258USD 585,2930USD 16,258 USD 6.48 USD 6.3
2025-11-07 (Friday)90,323USD 569,035MYGN holding decreased by -2710USD 569,0350USD -2,710 USD 6.3 USD 6.33
2025-11-06 (Thursday)90,323MYGN holding decreased by -296USD 571,745MYGN holding decreased by -24528USD 571,745-296USD -24,528 USD 6.33 USD 6.58
2025-11-05 (Wednesday)90,619MYGN holding decreased by -3552USD 596,273MYGN holding decreased by -12072USD 596,273-3,552USD -12,072 USD 6.58 USD 6.46
2025-11-04 (Tuesday)94,171USD 608,345MYGN holding decreased by -161974USD 608,3450USD -161,974 USD 6.46 USD 8.18
2025-11-03 (Monday)94,171MYGN holding decreased by -592USD 770,319MYGN holding increased by 8424USD 770,319-592USD 8,424 USD 8.18 USD 8.04
2025-10-31 (Friday)94,763USD 761,895MYGN holding increased by 8529USD 761,8950USD 8,529 USD 8.04 USD 7.95
2025-10-30 (Thursday)94,763USD 753,366MYGN holding increased by 3791USD 753,3660USD 3,791 USD 7.95 USD 7.91
2025-10-29 (Wednesday)94,763USD 749,575MYGN holding decreased by -20848USD 749,5750USD -20,848 USD 7.91 USD 8.13
2025-10-28 (Tuesday)94,763MYGN holding increased by 888USD 770,423MYGN holding increased by 10035USD 770,423888USD 10,035 USD 8.13 USD 8.10001
2025-10-27 (Monday)93,875USD 760,388MYGN holding decreased by -4693USD 760,3880USD -4,693 USD 8.10001 USD 8.15
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MYGN by Blackrock for IE00B3VWM098

Show aggregate share trades of MYGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-2966.7106.485 6.508USD -1,926 9.52 Profit of 893 on sale
2025-11-06SELL-2966.6006.210 6.249USD -1,850 9.59 Profit of 988 on sale
2025-11-05SELL-3,5526.8206.400 6.442USD -22,882 9.60 Profit of 11,228 on sale
2025-11-03SELL-5928.3807.774 7.835USD -4,638 9.63 Profit of 1,061 on sale
2025-10-28BUY8888.1308.170 8.166USD 7,251 9.66
2025-10-24SELL-2968.1508.160 8.159USD -2,415 9.68 Profit of 450 on sale
2025-10-15BUY1,7768.1008.130 8.127USD 14,434 9.75
2025-10-02BUY2967.5607.840 7.812USD 2,312 9.77
2025-09-30BUY5927.2307.290 7.284USD 4,312 9.79
2025-09-11BUY1,1847.6807.710 7.707USD 9,125 9.86
2025-08-21SELL-2385.8305.940 5.929USD -1,411 9.89 Profit of 942 on sale
2025-07-31BUY7113.8404.070 4.047USD 2,877 9.95
2025-06-30SELL-4745.3105.380 5.373USD -2,547 10.59 Profit of 2,472 on sale
2025-06-25SELL-2385.1205.200 5.192USD -1,236 10.70 Profit of 1,311 on sale
2025-06-20SELL-4764.9205.140 5.118USD -2,436 10.82 Profit of 2,716 on sale
2025-05-23BUY2383.9103.960 3.955USD 941 11.83
2025-05-19SELL-2384.4304.470 4.466USD -1,063 12.10 Profit of 1,816 on sale
2025-05-15SELL-7144.1104.120 4.119USD -2,941 12.24 Profit of 5,796 on sale
2025-05-12SELL-2384.2504.260 4.259USD -1,014 12.46 Profit of 1,951 on sale
2025-05-09SELL-2383.8904.230 4.196USD -999 12.54 Profit of 1,985 on sale
2025-04-30SELL-2387.4107.550 7.536USD -1,794 12.95 Profit of 1,288 on sale
2025-04-24SELL-4767.3707.460 7.451USD -3,547 13.17 Profit of 2,723 on sale
2025-04-17SELL-2387.6407.930 7.901USD -1,880 13.48 Profit of 1,327 on sale
2025-04-15SELL-7148.0108.150 8.136USD -5,809 13.60 Profit of 3,898 on sale
2025-04-14SELL-7148.0808.270 8.251USD -5,891 13.66 Profit of 3,859 on sale
2025-04-09SELL-9528.4508.590 8.576USD -8,164 13.84 Profit of 5,015 on sale
2025-04-07SELL-1,6668.0708.630 8.574USD -14,284 13.98 Profit of 9,010 on sale
2025-04-04SELL-2,3808.1308.500 8.463USD -20,142 14.05 Profit of 13,299 on sale
2025-03-31BUY2388.8709.020 9.005USD 2,143 14.24
2025-03-19SELL-4769.93010.060 10.047USD -4,782 14.74 Profit of 2,235 on sale
2025-03-14SELL-1,42810.07010.190 10.178USD -14,534 14.94 Profit of 6,803 on sale
2025-03-13SELL-4789.70010.470 10.393USD -4,968 15.02 Profit of 2,210 on sale
2025-03-12SELL-8,12610.41011.440 11.337USD -92,124 15.08 Profit of 30,443 on sale
2025-03-07SELL-47810.18010.590 10.549USD -5,042 15.31 Profit of 2,278 on sale
2025-03-06SELL-71710.52010.680 10.664USD -7,646 15.39 Profit of 3,387 on sale
2025-03-03SELL-23910.39010.900 10.849USD -2,593 15.63 Profit of 1,143 on sale
2025-02-28BUY9,20010.73011.220 11.171USD 102,773 15.71
2025-02-26SELL-21211.56011.890 11.857USD -2,514 15.86 Profit of 848 on sale
2025-02-25SELL-63611.74012.280 12.226USD -7,776 15.93 Profit of 2,356 on sale
2025-02-18BUY1,06014.57014.900 14.867USD 15,759 16.07
2025-02-13BUY21214.65014.780 14.767USD 3,131 16.16
2025-02-12BUY21213.09013.110 13.108USD 2,779 16.22
2025-02-11BUY63612.57012.800 12.777USD 8,126 16.29
2025-02-06BUY1,90812.73012.910 12.892USD 24,598 16.55
2025-01-27BUY21212.96013.170 13.149USD 2,788 17.37
2024-12-30BUY1,05513.63013.830 13.810USD 14,570 17.88
2024-12-06BUY84415.13016.630 16.480USD 13,909 18.16
2024-12-05BUY21116.36016.560 16.540USD 3,490 18.22
2024-12-04BUY1,05516.60016.830 16.807USD 17,731 18.28
2024-11-29BUY1,05516.27016.520 16.495USD 17,402 18.51
2024-11-27BUY84416.28016.530 16.505USD 13,930 18.70
2024-11-26BUY21116.17016.350 16.332USD 3,446 18.81
2024-11-25BUY19,03815.71016.150 16.106USD 306,626 18.96
2024-11-21BUY76515.12015.610 15.561USD 11,904 19.35
2024-11-20BUY45915.30015.330 15.327USD 7,035 19.57
2024-11-18BUY1,83615.22015.510 15.481USD 28,423 20.13
2024-11-12BUY1,21616.17017.450 17.322USD 21,064 20.39
2024-11-08BUY76017.41019.600 19.381USD 14,730 20.61
2024-11-07BUY2,28017.67018.420 18.345USD 41,827 20.83
2024-11-06BUY30417.57018.570 18.470USD 5,615 21.10
2024-10-31BUY15221.96022.810 22.725USD 3,454 22.23
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MYGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1998,7970263,14137.5%
2025-09-1887,7960406,68821.6%
2025-09-17144,0560336,24142.8%
2025-09-16159,5820394,91040.4%
2025-09-15173,5310356,20048.7%
2025-09-12273,0060766,55135.6%
2025-09-11264,8443855,09531.0%
2025-09-10115,5040320,17336.1%
2025-09-09117,8290834,12714.1%
2025-09-08293,5090568,19451.7%
2025-09-05142,1100429,58233.1%
2025-09-0490,0370255,78835.2%
2025-09-03187,8490373,12250.3%
2025-09-02417,098140736,94256.6%
2025-08-29210,7440471,70144.7%
2025-08-28218,7350367,38959.5%
2025-08-27141,0250200,61170.3%
2025-08-26124,1170205,57560.4%
2025-08-25130,42423225,71957.8%
2025-08-22167,0870332,61750.2%
2025-08-21227,6790355,89564.0%
2025-08-20274,77410542,34650.7%
2025-08-19182,97514441,62841.4%
2025-08-18197,8310527,42737.5%
2025-08-15209,8960350,46759.9%
2025-08-14326,2390825,82239.5%
2025-08-13283,8440647,80043.8%
2025-08-12241,6520445,08454.3%
2025-08-11333,2980591,64356.3%
2025-08-08353,2870848,90941.6%
2025-08-071,045,9832,1642,050,52451.0%
2025-08-063,016,8108,3557,314,58141.2%
2025-08-05346,937248635,53154.6%
2025-08-04156,2950344,86245.3%
2025-08-01183,7790522,49335.2%
2025-07-31353,60501,022,68134.6%
2025-07-30197,1690561,41435.1%
2025-07-29246,8101630,25439.2%
2025-07-28143,5020424,45733.8%
2025-07-25192,399207475,91140.4%
2025-07-24147,034100277,91752.9%
2025-07-23119,8030313,29038.2%
2025-07-22160,4822,781420,47338.2%
2025-07-21117,5930293,23940.1%
2025-07-18173,7980453,12138.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.